Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

eHealth (EHTH) Research & Development (2016 - 2025)

Historic Research & Development for eHealth (EHTH) over the last 15 years, with Q1 2025 value amounting to $12.6 million.

  • eHealth's Research & Development fell 529.12% to $12.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was $69.5 million, marking a year-over-year decrease of 109.81%. This contributed to the annual value of $53.5 million for FY2024, which is 868.3% down from last year.
  • As of Q1 2025, eHealth's Research & Development stood at $12.6 million, which was down 529.12% from $13.3 million recorded in Q1 2024.
  • In the past 5 years, eHealth's Research & Development registered a high of $23.2 million during Q1 2021, and its lowest value of $12.6 million during Q1 2025.
  • In the last 3 years, eHealth's Research & Development had a median value of $16.9 million in 2021 and averaged $17.4 million.
  • Per our database at Business Quant, eHealth's Research & Development skyrocketed by 5302.48% in 2021 and then tumbled by 529.12% in 2025.
  • eHealth's Research & Development (Quarter) stood at $20.5 million in 2021, then tumbled by 34.98% to $13.3 million in 2024, then fell by 5.29% to $12.6 million in 2025.
  • Its Research & Development stands at $12.6 million for Q1 2025, versus $13.3 million for Q1 2024 and $20.5 million for Q2 2021.